Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the ...

FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...

Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

These were among our most popular Trivia Tuesday articles this past year. Amanda Pedersen is a veteran journalist and ...

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen explores the potential over-reliance on a medical device ...

David Fischel, Stereotaxis CEO, talks about the market opportunity for the company’s surgical robotic solutions.

The Senate has rejected bipartisan ACA subsidy bills as millions face doubled premiums when financial assistance expires at ...

Building FDA submissions like a solid house requires early collaboration, proactive planning, and a clear regulatory story.

The medtech job market faces major shifts in 2026 due to federal layoffs, AI adoption, and M&A activity. Versatile skills ...

Peijia's TaurusTrio TAV system wins NMPA approval, revolutionizing severe AR treatment with Jenavalve's locator technology.

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.